{"denoms":[{"counts":[{"groupId":"OG000","value":"0"}],"units":"Participants"}],"description":"Patients will have routine restaging to assess disease response at Day 100, 6 months, 1 year, 18 months and 24 months. If disease relapse is suspected, the patient will be evaluated at that time.","groups":[{"description":"High dose conditioning with Fludarabine \\& Melphalan","id":"OG000","title":"Umbilical Cord Blood Transplant"}],"paramType":"NUMBER","populationDescription":"This study was terminated early. No participants were analyzed.","reportingStatus":"POSTED","timeFrame":"Day 100, 6 months, 1 year, 18 months, 24 months","title":"Number of Patients Who Experience Disease Relapse Post-transplant","type":"SECONDARY","unitOfMeasure":"participants"}